• 92
  • 10
  • 收藏

AstraZeneca shares fell nearly 3% as its third-quarter earnings missed expectations

Tiger Newspress2021-11-12

AstraZeneca shares fell nearly 3% in premarket trading.Total revenue jumped 47% to $9.74 billion for the three months to September on a constant-currency basis, while core earnings came in at $1.08 per share, the company said.

Analysts on average were expecting profit of $1.28 per share on sales of $9.4 billion, according to Refinitiv IBES data.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

举报

评论10

  • Trainman
    ·2021-11-13
    Mostlt used in Japan and Taiwan.
    回复
    举报
  • Kel9670ong
    ·2021-11-12
    Well, as more countries have achieved high vaccination rate the demand thus fall. It's therefore important for phrama to look beyond relying on covid vaccine
    回复
    举报
  • MoonMoon
    ·2021-11-12
    Like
    回复
    举报
    收起
    • MoonMoon
      Ok
      2021-11-12
      回复
      举报
  • MHh
    ·2021-11-12
    Oops… due to poor vaccine sales? Not the most optimal benefit compared to side effects…
    回复
    举报
    收起
    • MHh
      I wouldnt want the vaccine too haha
      2021-11-12
      回复
      举报
    • MFME
      yeah
      2021-11-12
      回复
      举报
  • HeroSmurf
    ·2021-11-12
    Gg
    回复
    举报
  • angskk
    ·2021-11-12
    Pls like thks
    回复
    举报
  • Galaxy88
    ·2021-11-12
    Ooh …
    回复
    举报
    收起
    • angskk
      😁
      2021-11-12
      回复
      举报
  • koolgal
    ·2021-11-12
    Astra Zeneca still made money just not up to expectations.  Hopefully the share price will recover soon.  Go Astra! 🚀🚀🚀🌙🌙🌙
    回复
    举报
    收起
    • koolgal回复Gackky
      Yes it is. Thanks for sharing
      2021-11-13
      回复
      举报
    • Gackky回复koolgal
      60 is lower than ATL [LOL]
      2021-11-12
      回复
      举报
    • koolgal回复Vincentttt
      Great idea.  Thanks for sharing
      2021-11-12
      回复
      举报
    查看更多 2 条评论
  • STSL
    ·2021-11-12
    Ok
    回复
    举报
    收起
    • Tohyx
      Tiger
      2021-11-12
      回复
      举报
  • 咸蛋超人POT
    ·2021-11-12
    all the expectations missed.
    回复
    举报
    收起
    • kungpao
      yes
      2021-11-12
      回复
      举报
    • chaicka
      Signs were all over the wall when many countries ditched AZ and switched to mRNAs.
      2021-11-12
      回复
      举报
    • ILFTS
      Like please
      2021-11-12
      回复
      举报
 
 
 
 

热议股票

 
 
 
 
 

7x24